Objectives: The aim of this study was to determine the prevalence of bile cast nephropathy (BCN) in autopsied cirrhotic patients and to correlate BCN with clinical and laboratory data to direct attention to this underrecognized renal complication of liver failure.
Results: Bile casts were identified in 55% of cases. The most common etiology of cirrhosis was hepatitis C virus (HCV) infection (52%), and serum creatinine (P ¼ .02) and serum urea nitrogen (P ¼ .01) were significantly higher in the Hall-positive group. Conjugated bilirubin was below 20 mg/dL in 90%, and levels below 10 mg/dL were noted in 80% of cases.
Conclusions: To our knowledge, this is the largest study of BCN in human subjects and a first report describing the association of BCN with HCV-related cirrhosis. We demonstrated that in the face of protracted chronic hyperbilirubinemia, bile casts are formed at much lower bilirubin levels than previously thought. Furthermore, we proposed an algorithm to assist in better identification of bile casts.
Bile cast nephropathy (BCN) evolved from the broader, historical entity termed cholemic nephrosis or bile nephrosis, which encompassed kidney injury in jaundiced patients regardless of the presence of bile casts within renal tubules. BCN is defined as the presence of intratubular bile casts associated with kidney dysfunction in the setting of liver disease. The role of bile cast deposition in renal tubules has been largely overlooked by clinicians and pathologists until the recent reemergence of BCN.
1,2 Difficulty identifying bile casts on routine H&E sections and the uncertainty of their clinical significance contributes to the neglect of these casts. BCN has been described in a wide spectrum of liver failure, and its prevalence in a recent autopsy study of jaundiced patients was 55%. 1 There is a need for further research studying the effects of bile and bilirubin on renal dysfunction in cirrhotic patients. 3 Cases of BCN associated with hepatitis C virus (HCV) infection have been demonstrated only in individuals with a history of concomitant alcohol use. To this date, bile casts have not been described in cirrhotic patients with isolated HCV-related cirrhosis. This apparent correlative absence may fail to prompt investigation into the underlying factors contributing to renal dysfunction, which, in turn, deters the diagnosis of BCN in patients with cirrhosis due to viral hepatitis infection. The clinical implications, prognostic laboratory parameters, and management strategies of BCN are still largely unknown. Furthermore, due to overlapping features, the relationship between BCN and hepatorenal syndrome (HRS) has not been fully elucidated. The high prevalence of HCV infection in our patient population allows for a thorough assessment of HCV-related cirrhosis, which is a subset of cirrhotic patients in which BCN has not been previously described. The purpose of our study was to investigate the associated clinical and laboratory findings in correlation with the pathologic features of bile casts and to gain a better understanding of the histologic appearance of bile casts so that pathologists will be more adept at accurately recognizing and distinguishing these casts from similar lesions.
Materials and Methods

Clinical Data
We conducted a retrospective review of autopsy cases at the University of Texas Medical Branch, Galveston, over a 2-year period (April 1, 2011, to April 1, 2013) to identify patients with a diagnosis of cirrhosis. As study cases were not living human subjects, institutional review board approval was not required; however, the study was reviewed by an ad hoc committee of ethicists and pathologists (including the director of the autopsy division) to ensure appropriate protection of sensitive health information. The search yielded 114 cases, of which 98 cases were available for review. Demographic data, including age, sex, height, and weight, were compiled. Race was not included. Laboratory data closest to the time of death were gathered and included serum creatinine (SCr), serum urea nitrogen, total bilirubin, conjugated bilirubin, unconjugated bilirubin, alanine aminotransferase (ALT), aspartate aminotransferase (AST), and routine laboratory urine analysis. Estimated glomerular filtration rate (eGFR) was calculated from SCr using the Cockcroft-Gault equation. A considerable number of autopsies were performed on inmates in whom SCr was only randomly checked. Therefore, the authors categorized the SCr as SCr collected within 1 year prior to death, as well as within 3 months and within 1 week of death. To demonstrate the acute nature of renal failure, available data for SCr and eGFR collected within 1 week of death were compared with data collected within 3 months of death. The etiology of cirrhosis, including history of alcohol abuse, viral hepatitis serology, and HCV genotyping, was recorded. A history of alcohol abuse was defined as clinical diagnosis of alcohol abuse or alcoholic cirrhosis or if the individual met criteria for moderate drinking (at least one drink per day for women and two drinks per day for men); individuals with a remote history of alcohol use or those listed with "occasional" alcohol use were not considered. Comorbidities of diabetes mellitus and hypertension were documented. A clinical history of HRS was documented in only five patients and therefore could not be further assessed. Macroscopic autopsy findings were evaluated for the presence of jaundice, scleral icterus, and kidney and liver findings. The amount of abdominal aortic atherosclerosis was classified based on the percentage of surface area involved: none (no atherosclerosis or fatty streaks), minimal (5%-24%), mild (25%-49%), moderate (50%-74%), or severe (75%-100%).
Therapy
Concerning renal replacement therapy (RRT), from the original 114 autopsies, nine patients had either continuous venous-venous hemofiltration dialysis (CCVHD) or hemodialysis. From these nine autopsy cases, two cases were eliminated due to severe autolysis, and data on the remaining seven cases showed that they all were treated with CVVHD. Liver support systems such as the molecular adsorbent recirculation system or single-pass albumin dialysis were not performed on any of the patients.
Histology
In all cases, formalin-fixed, paraffin-embedded (FFPE), 3-lm-thick sections of renal tissue stained with H&E and Masson trichrome (MT) were reviewed by three observers (M.F., H.M.R., and M.A.) for the presence of tubular casts. In all cases, FFPE tissue sections were stained with Hall (Fouchet) stain with a van Gieson counterstain to detect bile casts. 4 The Hall method on FFPE tissue uses the Fouchet reagent to oxidize bilirubin into biliverdin, thereby staining bile casts a green color ranging from olive to emerald depending on the concentration of bilirubin. 5 Inclusion criteria for bile casts included either definitive positivity on Hall stain (emerald green color) or olive green casts on Hall stain that would also show fuchsinophilia and ragged borders on MT stain. The presence of at least one intratubular Hall-positive cast was considered the minimum criterion for BCN. Quantification of Hall-positive bile casts was done by scanning the entire section at 20Â. Cases were divided based on the presence or absence of bile casts on Hall stain into Hallpositive or Hall-negative groups. Casts containing a mixture of blue-stained material (hyaline) and red-stained fuchsinophilic material on MT were termed mixed casts. Periodic acid-Schiff (PAS) stains were reviewed in 20 Hall-positive and nine Hall-negative cases; by PAS, mixed casts were those staining both bright magenta and dark red-purple.
Renal tissue was assessed for the presence of pathologic changes in all four renal compartments, including glomeruli, tubules, interstitium, and vessels. Glomeruli were examined for the presence of mesangial proliferation, glomerular ischemic changes (ie, glomerular basement membrane wrinkling, thickening, and duplication of the Bowman capsule), and cryoglobulins. Tubular changes other than casts consisted of acute tubular necrosis, vacuolization of tubular epithelial cell cytoplasm, and tubular atrophy. The interstitium was examined for the presence of edema, fibrosis, and inflammatory cell infiltration. Interstitial fibrosis and tubular atrophy were disregarded in the immediate subcapsular areas. For slides with tubular casts, the presence or absence of adjacent acute tubular necrosis, interstitial inflammation, tubular atrophy, or interstitial fibrosis was noted. Vascular pathology included the presence or absence of arteriolar hyalinosis, and arterial fibrous intimal thickening was graded based on the amount of luminal narrowing: none (0), up to 25% (1þ), 26% to 50% (2þ), and greater than 50% (3þ). The presence of nephrosclerosis was defined as a history of hypertension with arteriolosclerosis or 20% or more global glomerular sclerosis and obsolescence, with or without granular kidney surface. 6 Other pathologic findings were also noted. If autolysis was present in a case and interfered with the assessment of a particular parameter, the case was excluded from statistical analysis of the parameter that could not be assessed. Cases with severe autolysis were eliminated from evaluation all together.
Positive Control Group
Positive control for Hall staining consisted of liver tissue obtained from an autopsy case of cirrhosis with bile stasis.
Negative Control Groups
Two negative control populations were selected from autopsy cases; the first included decedents with renal disease with no clinical or pathologic diagnosis of liver disease (18 cases), and the second group consisted of individuals with neither renal nor liver disease (18 cases). H&E-stained kidney sections were reviewed for the presence of intratubular granular casts. Most of these cases did not have any granular casts. Only in 11 cases in the first control group and one case in the second group were granular casts found on H&E. These 12 cases were subsequently evaluated for casts that showed fuchsinophilia with ragged borders on MT and olive to emerald green on Hall stains. Two cases showing browngreen staining by Hall were only mildly fuchsinophilic but with smooth borders and were excluded from the control group.
Statistical Analysis
Correlations between the Hall-positive and Hallnegative groups were performed to determine the relationship among clinical, laboratory, and macroscopic findings in relation to the presence of bile casts. Binary outcome variables were compared using the two-proportions test, and Fisher exact test (two-tail) was reported. All continuous variables are reported as means and standard deviations and were compared using the unpaired t test between the two cohorts. The Mann-Whitney test was used to examine the degree of abdominal aortic atherosclerosis and grade of arterial fibrous intimal thickening. The Wald F test was used to compare SCr and bilirubin levels with quantified bile casts in tissue sections. Nominal logistic regression analysis was performed to assess the potential association between bile casts, hypertension, diabetes mellitus, arteriolar hyalinosis, interstitial fibrosis, and tubular atrophy; results are reported as odds ratio (OR) and 95% confidence interval (CI). A P value of .05 or less was considered statistically significant. We performed additional statistical analyses after excluding cases with diabetes, hypertension, and diagnosis of nephrosclerosis to eliminate confounding factors in determining the relationship between BCN and interstitial fibrosis, tubular atrophy, and arteriolar hyalinosis.
Clinical Results
Demographics
A total of 94 cirrhotic cases were included in the statistical analysis after four cases were excluded due to severe autolysis. Bile casts were identified in 52 (55%) of 94 cases. Most autopsies were male (91/94; 97%) with a mean 6 SD age of 55 6 7.9 years (range, 33-79 years). There was no significant difference in age (55.4 6 8.6 vs 54.5 6 6.9 years, P ¼ .57), height (173.6 6 9.5 vs 173.9 6 10.5 cm, P ¼ .89), and weight (88.1 6 18.7 vs 87.8 6 21.9 kg, P ¼ .95) between the Hall-positive and Hall-negative groups, respectively. One-fourth of the decedents had a clinical history of diabetes mellitus and half had hypertension, but there was no significant difference regarding these comorbidities between the two groups (P ¼ .42 and P ¼ .21, respectively). Cause of death was related to cirrhosis in most cases (81). Specific causes included gastrointestinal hemorrhage (22; esophageal varices in 15, duodenal or gastric ulcers in seven, or gastropathy in one), hepatocellular carcinoma (18), sepsis/ infection (16), diffuse alveolar damage (11), atherosclerosis (5), hepatic encephalopathy (11), and cirrhosis not otherwise specified (11) . Other contributory causes included concomitant human immunodeficiency virus, nonhepatocellular malignancy, hematologic disease, cardiovascular disease, and pulmonary disease.
Etiology of Cirrhosis
Etiologies of cirrhosis in relationship to bile casts are shown in Table 1 . Of the three most common etiologies of cirrhosis, bile casts were detected in 28 (57%) of 49 HCVonly cases, 17 (53%) of 32 combined HCV/alcohol-related cases, and four (80%) of five cases due to alcohol alone. HCV genotyping was performed on 29 individuals, with the most frequent genotype being type 1 (76%), followed by type 3 (17%) and type 2 (7%). Other causes of cirrhosis included hepatitis B virus (HBV)-related cirrhosis, combined HCV/HBV-related cirrhosis, combined HCV/HBV/alcoholrelated cirrhosis, and primary biliary cirrhosis. HBV infection was confirmed by serology and included three individuals with immunity secondary to HBV (HBV core antibody positive, HBV surface antibody positive, and HBV surface antigen negative) and two carrier state individuals (HBV surface antigen positive, HBV surface antibody negative, and HBV core antibody negative). Two cases also had the diagnosis of cryptogenic cirrhosis, one of which was seropositive for hepatitis A virus. No correlation was found between the two groups regarding the etiology of cirrhosis. Of the five individuals with a clinical diagnosis of HRS, four had bile casts.
Renal Function Tests
Data for serum urea nitrogen, SCr, and eGFR were available for 91 (97%) of 94 individuals (date range, 0-387 days from death). Serum urea nitrogen was higher in the Hall-positive group (35.8 6 24.1 vs 26.6 6 15.9 mg/dL, P ¼ .01). SCr and eGFR were performed within 3 months and 1 week prior to death in 92% and 63% of cases, respectively, and are shown in Table 2 . SCr was higher in the Hall-positive group when performed within 1 week of death (P ¼ .02). eGFR was significantly decreased in the Hallpositive group compared with the Hall-negative group when performed within 1 week prior to death (P ¼ .03). In addition, when comparing results performed within 1 week of death to those taken prior to 1 week of death, only in the Hall-positive group was SCr greater (2.8 6 2.2 vs 1.4 6 1.8 mg/dL, P ¼ .01) and eGFR lower (61.5 6 44.0 vs 80.2 6 49.8 ml/min/per 1.73 m 2 , P ¼ .004). RRT in the form of CVVHD was performed in only seven patients, of whom four were in the Hall-positive group and had serum bilirubin levels above 22 mg/dL.
Liver Transaminases
Data for ALT and AST were available for 91 (97%) of 94 cases and are shown in Table 3 . Tests were performed within 3 months and 1 week of the time of death in 90% and 52% of cases, respectively (date range, 0-399 days). No significant difference in ALT was found between the two groups. Similarly, no significant difference was found for AST; however, it was observed that the data were skewed by 10 cases with an AST greater than 400 IU/L. Eight of 10 of these individuals had laboratory assessment of AST within 1 week of death. Upon exclusion of cases with AST greater than 400 IU/L, it was found that Hall-positive cases had significantly more elevated AST (P ¼ .005) compared with the Hall-negative group.
Urine Analysis
No significant difference was found between the Hallpositive and Hall-negative groups in terms of urine analysis: urine-specific gravity (1.018 6 0.008 vs 1.017 6 0.008, P ¼ .84), urine RBCs (P ¼ .74), urine WBCs (P ¼ .54), urine bilirubin (P ¼ .29), urine urobilinogen (P ¼ .59), and urine casts (P ¼ .66). Urine analysis data were available for 87 (93%) of 94 of cases; however, 72% of results were performed within 3 months, but only 30% were performed within 1 week of death.
Pathologic Results
Macroscopic Findings
Pathologic findings are displayed in Table 4 . Hallpositive cases had a statistically significant association with the presence of jaundice (P < .01), scleral icterus (P < .01), granular/scared renal cortices (P ¼ .03), and a green/yellow liver appearance (P ¼ .05). There was no difference between the two groups in terms of liver weight (mean of 1,430 g in Hall-positive cases vs 1,350 g in Hall-negative cases, P ¼ .67). Abdominal aortic atherosclerosis was absent in 28 (30%) of 94 individuals. The severity of atherosclerosis was minimal in 31 (33%) of 94, mild in 14 (15%) of 94, moderate in 11 (12%) of 94, and severe in 10 (11%) of 94 cases. There was no statistically significant difference between the two groups for the presence of abdominal aortic atherosclerosis (P ¼ 1.00) or the amount of abdominal aortic atherosclerosis when compared by grade (P ¼ .67). Percentages ¼ n/N Â 100 (total number is listed in the column heading).
Microscopic Findings
On H&E, bile casts had a granular red-brown appearance Image 1A and correlated with the presence of Hallpositive casts (P < .01). Their color ranged from drab olive to emerald green on Hall stain Image 1B . By MT, bile casts were fuchsinophilic with ragged contours and sometimes contained cellular debris Image 1C ; these casts were seen in 41 (79%) of 52 Hall-positive cases and in only three (7%) of 42 Hall-negative cases (P < .01). In the negative control group, none of the cases contained fuchsinophilic casts with ragged borders staining positively with Hall. Bile casts stained amaranth purple on PAS, which had a deeper red hue than the typical bright magenta of tubular basement membrane Image 1D . Some casts had characteristics of Pathologic changes seen immediately adjacent to the bile casts included acute tubular necrosis (10/52; 19%), tubular atrophy (14/52; 26%), interstitial fibrosis (10/52; 19%), and interstitial inflammation (2/52; 4%). No intracytoplasmic bile was observed within tubular epithelial cells. An initial evaluation of the entire data set by the two-proportions test showed that tubular atrophy (P < .01), interstitial fibrosis (P < .01), and arteriolar hyalinosis (P < .01) each correlated with the presence of bile casts. Regression analysis also revealed a statistically significant association between the presence of bile casts and tubular atrophy (OR, 3.58; 95% CI, 1.4-9.7; P ¼ .007), interstitial fibrosis (OR, 3.80; 95% CI, 1.6-9.7; P ¼ .003), and arteriolar hyalinosis A B
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Image 1 Staining characteristics of bile casts. A, Bile cast resembling a granular cast (H&E, Â400). B, Hall positivity in a tubular cast (Hall stain, Â400). C, Bile casts with red and ragged appearance on the left. On the right, a mixed cast with characteristics of both a hyaline cast (stained blue) and a bile cast (stained red) (Masson trichrome, Â400). D, Bile cast on periodic acid-Schiff (PAS) stain (PAS, Â400).
(OR, 3.99; 95% CI, 1.5-11.5; P ¼ .004), confirming our initial findings. Other renal histopathologic findings not showing a statistically significant correlation with BCN included glomerular basement membrane wrinkling (P ¼ .67), acute tubular necrosis (P ¼ .37), tubular vacuolization (P ¼ .63), interstitial inflammation (P ¼ .61), interstitial edema (P ¼ .21), preexisting renal disease (P ¼ 1.00), and arterial fibrous intimal thickening (P ¼ .17). Even when arterial fibrous intimal thickening was assessed by grade, no difference was seen between cases with bile casts and those without (P ¼ .32). Mesangial proliferation and presence of cryoglobulin were not seen in a single case. Other pathologic diagnoses in the kidney noted in the autopsy report included nephrocalcinosis, focal segmental glomerulosclerosis, acute pyelonephritis, papillary adenoma, renal cell carcinoma, metastatic squamous cell carcinoma, and nodular glomerulosclerosis.
Nephrosclerosis was seen in 65% of all cases examined. To evaluate whether confounding factors were attributed to tubular atrophy, interstitial fibrosis, and arteriolar hyalinosis, we repeated our analysis after excluding cases with a clinical history of hypertension or diabetes, a diagnosis of nephrosclerosis at the time of the autopsy, or the presence of nephrosclerosis detected in the tissue. Upon exclusion, the difference between Hall-positive and Hall-negative cases was no longer statistically significant for the three parameters: tubular atrophy (15/20 vs 8/13, P ¼ .41), interstitial fibrosis (15/20 vs 6/13, P ¼ .09), and arteriolar hyalinosis (9/20 vs 1/11, P ¼ .055).
Discussion
To our knowledge, our study is the largest clinicopathologic review of BCN reported to date in the literature and is also the largest series evaluating BCN in cirrhotic patients. BCN was a common phenomenon in cirrhotic patients at autopsy, with 55% of cases showing the lesion in the tubules, which is comparable to the incidence reported by van Slambrouck and colleagues 1 in a recent study that included 23 patients with cirrhosis. Interestingly, they found bile casts in 100% of cases of alcohol-related cirrhosis and 50% of combined HCV/alcohol-related cirrhosis (n ¼ 10 and n ¼ 4, respectively), but bile casts were consistently absent in all cases of HCV-related cirrhosis (n ¼ 5). In contrast to previous studies that assessed for bile casts in populations with acute and subacute liver failure or obstructive jaundice, our study focuses specifically on patients with cirrhosis. In our study, HCV was the sole etiology of cirrhosis in 52% of our autopsies, and bile casts were found in over half of these cases. It is interesting that despite this alarming number of cases, BCN remains a rarely diagnosed entity. The tendency to underdiagnose BCN is multifactorial and stems from the difficulty in assessing renal function in cirrhotic patients and a general lack of awareness of this condition as a diagnostic entity rather than a histologic correlate of liver disease. The factors accounting for this underdiagnosis include lack of awareness of this entity, failure to recognize bile casts on routine staining, and the limited availability and technical difficulty of performing the Hall stain. In addition, renal biopsies are uncommonly performed on patients with end-stage liver disease often because of associated coagulopathy; therefore, histologic evaluation of the kidneys for bile casts may only occur at autopsy.
To understand the pathogenesis of BCN, animal models were developed to mimic the relationship between jaundice and renal dysfunction. These early animal studies yielded conflicting results, [7] [8] [9] [10] [11] [12] [13] [14] and only a small subset of cases documented the presence of bile casts. [7] [8] [9] [10] [11] More recent animal studies using mice showed renal interstitial inflammation, fibrosis, and endothelial injury. 1 It should be noted that animal models are helpful in assessing acute changes; however, chronic changes (like those seen in liver cirrhosis) are harder to assess. 15 Bile casts have also been described in pediatric cirrhosis secondary to biliary cirrhosis, HBV, and neonatal hepatitis, 16 but information on cirrhotic adults is scanty. Five cases of HCV-related cirrhosis were included in a prospective study comparing tubular dysfunction in patients with subacute hepatic failure to patients with cirrhosis; bile casts were found in three patients with subacute hepatic failure, but histologic evaluation was not performed on the cirrhotic cases. 17 One of the earliest autopsy series evaluating cholemic nephrosis studied 75 patients with acute liver necrosis and found histologic changes, including glomeruli congestion, tubular vacuolization and necrosis, and interstitial inflammation with edema, but only two cases demonstrated renal tubular bile casts. 10 van Slambrouck et al 1 reported a correlation between the extent of bile cast formation and the extent of acute tubular injury, and they noted mild interstitial fibrosis and tubular atrophy in cases with bile casts. Similar to previous studies, we saw tubular epithelial cell vacuolization, vascular congestion, and interstitial edema, but in our study, there was no significant difference between Hall-positive and Hall-negative cases.
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Pathogenesis
Several hypotheses regarding the mechanism of renal failure in conjunction with bile casts have been proposed, but details of the exact pathogenesis are still under evaluation. 18 The two theories regarding the pathophysiological mechanism of renal injury in BCN are direct toxicity of bilirubin and bile acids to the tubular epithelium 2, 3, [15] [16] [19] [20] [21] and mechanical tubular obstruction by casts.
The theory of direct toxicity suggests that bilirubin and bile salts damage the renal tubular epithelium through direct toxicity, causing epithelial cell sloughing and formation of bile casts, resulting in acute tubular injury. Physiologic levels of bile are not toxic to the renal epithelium, but both bilirubin and bile acids can disrupt cellular and mitochondrial integrity. Some authors have argued that bilirubin may not be toxic to the kidneys and may in fact have a reno-protective effect, 18 while others have claimed that hyperbilirubinemia can lead to a reversible nonacidotic proximal tubulopathy via tubular dysfunction or injury. 22 Other elevated substances during cirrhosis implicated in renal injury include vasoactive endothelin 1, 23, 24 tumor necrosis factor-a, 3, 25, 26 interleukin 17A, 3, 27, 28 and renal-excreted cholephiles. 15 Systemic inflammatory response syndrome and increased intraabdominal pressure have been considered important nonvasomotor mechanisms that affect kidney function in cirrhosis, 3 and gastrointestinal factors have been shown to influence renal dysfunction in patients with liver disease through bacterial translocation in the gut, 3, 29 leading to elevations in renal Tolllike receptor expression 3, [30] [31] [32] and endotoxemia associated with gastrointestinal hemorrhage. 3, 20, [33] [34] [35] [36] Hemodynamic alterations are the current understanding of the pathophysiological mechanism underlying HRS. Although hemodynamic alterations have also proposed mechanism suggested for BCN, they do not represent only the current accepted mechanism for development of BCN. In HRS, renal vasoconstriction is believed to arise due to a combination of splanchnic vasodilation, sympathetic nervous system stimulation, cardiac dysfunction, and circulating cytokines and vasoactive mediators acting on the renal circulation. 37 BCN has been described in patients with HRS 1,7,10 who have acute kidney injury in the background of liver disease. 37, 38 Renal arteriolar vasoconstriction in chronic liver disease is a well-known phenomenon and is mediated through both neural and humoral mechanisms. 39 Previous studies have shown a spectrum of abnormalities in the renal circulation of patients with chronic liver disease such as constriction of the interlobular and arcuate arteries 40 and glomerular hyperfiltration due to reduced renal resistance and preferential afferent arteriolar dilatation. 41 Clinically, the tubular epithelial toxicity due to bile casts should allow the fractional excretion of sodium to distinguish BCN from HRS. 37, 42, 43 A limitation of our study is the difficulty evaluating for HRS in autopsy studies, which relies on clinical diagnostic parameters, such as failed management with albumin therapy 38 that cannot be assessed after death. In our series, five cases had a premortem diagnosis of HRS; four of these cases had bile casts, which is comparable to the 11 of 13 cases with bile casts and HRS reported by van Slambrouck et al. 1 
Staining Properties of Bile Casts
Diagnosis of BCN depends on pathologists' awareness of this entity and recognition of the staining characteristics of bile casts on routine staining. Several casts may have a similar brown or granular appearance on H&E, and key distinguishing features are outlined in Table 5 . The usefulness of MT deserves emphasis as a valuable screening tool for bile casts; although other casts are also fuchsinophilic by MT, bile casts can be differentiated by their ragged contour. Other casts that appear red on MT include myeloma, hemoglobin, and myoglobin casts. Myeloma casts are fractured casts characteristically surrounded by multinucleated giant cells, are highly refractile on H&E, and appear bright magenta by PAS and brown on Hall stain. They lack the ragged appearance of bile casts and usually have smooth lateral borders. Hemoglobin and myoglobin casts lack the red hue of bile casts on PAS and also are yellow-brown by Hall stain. An important observation is that not all bile casts are pure, but many are mixed with hyaline casts (TammHorsfall protein) and therefore exhibit staining characteristics of both casts. Mixing of bile with Tamm-Horsfall protein has been reported 6 ; however, the staining properties of mixed casts have not been defined. The appearance of mixed casts on both MT and PAS stains also adds further information that can be helpful in recognizing BCN. In our study, fuchsinophilic ragged casts and mixed casts were more commonly seen in the Hall-positive cases but were only rarely seen in Hall-negative cases. For screening of renal biopsy specimens in cirrhotic patients, we believe that close screening with MT-stained sections can help reduce false-negative rates in the detection of bile casts, particularly in cases in which few granular casts were seen on H&E. As MT screening on all autopsy cases might prove to be costly, we suggest the use of MT stain when there is a history of impaired renal function associated with hyperbilirubinemia. We also suggest that an MT-stained section be examined first to search for potential bile casts; Hall stain, which is a more specialized and difficult stain to perform, can then be ordered for confirmation.
Application of Clinical Laboratory Data
A confounding factor in the assessment of renal function in cirrhotic patients is the consistent underestimation of SCr in cirrhotic patients. Reduced creatinine production by the liver, malnourishment leading to decreased muscle mass, and the increased rate of tubular creatinine secretion contribute to the lower than expected SCr in cirrhotic patients. 44 Similarly, methods to calculate eGFR such as the Cockcroft-Gault and Modification of Diet in Renal Disease formulas, inherently overestimate the glomerular filtration rate by failing to adjust for ascites and volume expansion in liver disease. Dependency of these formulas on variables such as albumin and ideal body weight limits their use in patients with liver failure and should be used with caution. We know also that elevations in free, or unbound, bilirubin due to hypoalbuminemia can affect renal function. 2 Although we refrain from making any conclusions on renal function, attention should be given to the following points: SCr was equally underestimated in both the Hall-positive and Hallnegative groups, yet despite the underestimation of SCr in cirrhosis, our results show SCr to be significantly elevated in cirrhotic patients with BCN. The finding of elevated SCr only within 1 week prior to death supports the impact and increasing severity of BCN near the time of death. Bilirubin closely mirrors trends of SCr elevations in patients with BCN. 19, 45 Prior studies indicated that a bilirubin threshold of more than 20 mg/dL is required for the formation of bile casts 1, 20, 46 ; however, we found that most of our cases had bilirubin levels less than 20 mg/dL, and actually 80% of cases had conjugated bilirubin levels of less than 10 mg/dL. Our explanation for this discrepancy is related to the fact that our patient population consisted of cirrhotic patients (ie, patients with long-term hyperbilirubinemia), as opposed to previous studies in which hyperbilirubinemia was due to acute liver failure or obstructive jaundice. It is feasible that low-level hyperbilirubinemia may allow bile accumulation in renal tubules over a long duration, thus resulting in the formation of bile casts. A second possibility is that chronic low-level elevated bilirubin and bile acids may injure the tubules over time or may have a "priming effect" on tubules, preparing the ground for the occurrence of BCN at lower serum bilirubin levels. Thus, to manifest itself, BCN does not necessarily need to be associated with bilirubin levels above 20 mg/d, as has previously been thought. In other words, while serum bilirubin levels above 20 mg/dL are needed for the formation of bile casts in acute liver failure, in chronic liver diseases, much lower levels of serum bilirubin could potentially lead to the formation of bile casts. Therefore, BCN must still be considered in cirrhotic patients with renal failure even without high-level hyperbilirubinemia. Several of our cases with bile casts on histology had normal serum bilirubin levels. This finding is specifically intriguing, as it stresses the smoldering impact of chronic hyperbilirubinemia on renal tubules. Interstitial fibrosis and tubular atrophy were seen more often in cases with BCN, suggesting that chronic episodic hyperbilirubinemia in cirrhosis leads to protracted kidney injury. The latter concept opens the door for exploration of new animal models to investigate chronic liver disease and BCN. Conversely, we also showed absence of histologic evidence of bile casts in individuals with severely elevated bilirubin, indicating that high-level hyperbilirubinemia does not guarantee the formation of bile casts. Therefore, bilirubin levels alone cannot be used as an absolute criterion for the suspicion of BCN.
Different diagnostic algorithms are being used to guide clinicians concerning treatment strategies. Recently, the "conventional criterion" used by hepatologists was compared with the Acute Kidney Injury Network (AKIN) criteria used by nephrologists in evaluating cirrhotic patients. 47 The conventional criterion defines acute kidney injury as an increase of SCr of 50% or more to a final value of 1.5 mg/ dL, while the AKIN criterion defines acute kidney injury as an increase of 0.3 mg/dL or more in less than 48 hours or an increase in SCr of 50% or more from baseline. The comparison suggested improvement in the prediction of morbidity and mortality when using the AKIN criterion, but the results were inconclusive. 47, 48 Thus, standard treatment criteria are not in place for all patients, and the criteria used in cirrhotic patients with acute kidney injury depend on subspecialty training. To add to the complexity, BCN is a diagnosis with severe clinical implications that depends on histologic evidence of bile casts within the renal tubules, yet renal biopsies are seldom performed on cirrhotic patients due to contraindications such as increased bleeding risk secondary to coagulopathy. This creates a situation in which it becomes critical to define surrogate clinical and laboratory parameters to raise the suspicion of BCN. Improvement of renal function in BCN can be achieved and was observed in jaundiced patients with cholelithiasis following resolution of jaundice 22 and was demonstrated by successful kidney transplantation from donors with HRS. 49 The importance of recognizing BCN is related to the fact that once diagnosed, it is a potentially reversible phenomenon, and kidney function can be preserved if liver transplantation is performed. Sequeira and Gu 2 suggest that concurrent BCN may delay recovery in patients with HRS, and kidney biopsy may be needed to ascertain diagnostic and prognostic information. For prospective transplant patients, the diagnosis of BCN may have a role in determining the need for combined liver and kidney (CLK) transplant in patients with renal and hepatic failure. Comparison of CLK transplantation vs liver transplant alone (LTA) found higher posttransplantation renal failure rates for patients undergoing LTA possibly attributable to bile cast damage. 50 Acquiring renal biopsy prior to transplant allocation may identify patients with BCN instead of HRS and could serve as an organ-sparing strategy.
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Conclusion
We hope to have increased awareness of BCN as a diagnostic entity by demonstrating bile casts in more than half of cirrhotic individuals at the time of autopsy in the largest study on BCN in cirrhotic subjects to date. We have also illustrated a first report occurrence of bile casts with HCVrelated cirrhosis. Although BCN is associated with a more profound hyperbilirubinemia, in a chronic setting such as cirrhosis, a specific serum bilirubin cutoff level for the formation of intratubular bile casts is not recommended, and bilirubin levels alone should not be used as the criterion for clinical suspicion of BCN. We report the staining characteristics of bile casts on H&E, MT, and PAS and highlight their usefulness for screening for this disease. Our study lends support to the theory of tubular toxicity, but additional studies are necessary to further elucidate the pathogenesis of BCN and to determine the clinical implications of BCN in patients being assessed for liver transplantation.
